https://doi.org/10.1371/journal.pone.0114110.g003
M
Mike Martin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
128
Citations
4
h-index
3
i10-index
Mike Martin is an academic researcher from University of Zurich. The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & 3D Printing in Biomedical Research & Nitric Oxide and Endothelin Effects. The author has an h-index of 4, co-authored 15 publications.
Papers by this author
works3-MA prevents LC3 accumulation and reduces cediranib/quinacrine efficacy.
2015 · Figshare · 0 citations
The effect of hypoxia and cediranib/quinacrine on LC3.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0114110.g002
Cediranib and quinacrine inhibit Akt activation.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0114110.g004
Hypoxia's presence <i>in vivo</i> and its effect on cediranib/quinacrine efficacy <i>in vitro</i>.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0114110.g001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat